Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB04897> ?p ?o ?g. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB04897 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04897 label "Lucinactant [drugbank:DB04897]" assertion.
- drugbank:DB04897 seeAlso DB04897 assertion.
- drugbank:DB04897 seeAlso lucinactant.html assertion.
- drugbank:DB04897 seeAlso surfaxin-drug.htm assertion.
- drugbank:DB04897 identifier "drugbank:DB04897" assertion.
- drugbank:DB04897 description "Lucinactant is a new synthetic peptide-containing surfactant for intratracheal use. It contains sinapultide, a novel, hydrophobic, 21-amino acid peptide (leucine and lysine repeating units, KL4 peptide) designed to mimic human surfactant protein-B (SB-P). More specifically, it mimics the C-terminal amphipathic helical domain of this protein. It also consists of phospholipids (dipalmitoylphosphatidylcholine, DPPC and palmitoyloleoyl phosphatidylglycerol, POPG) and a fatty acid (palmitic acid). It is completely devoid of animal-derived components. FDA approved on March 6, 2012." assertion.
- drugbank:DB04897 title "Lucinactant" assertion.
- drugbank:DB04897 bio2rdf_vocabulary:identifier "DB04897" assertion.
- drugbank:DB04897 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04897 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04897" assertion.
- drugbank:DB04897 bio2rdf_vocabulary:x-identifiers.org DB04897 assertion.
- drugbank:DB04897 drugbank_vocabulary:drugbank-id "DB04897" assertion.
- drugbank:DB04897 drugbank_vocabulary:x-cas cas:825600-90-6 assertion.
- drugbank:DB04897 drugbank_vocabulary:x-ahfs ahfs:48:36 assertion.
- drugbank:DB04897 drugbank_vocabulary:x-atc atc:R07AA30 assertion.
- drugbank:DB04897 drugbank_vocabulary:x-wikipedia wikipedia:Lucinactant assertion.